Oct 20, 2026 06:33AM

Oct 19, 2026 05:31AM

Oct 12, 2026 06:05AM

Oct 6, 2026 06:32AM

Sep 23, 2026 08:14AM

Jun 23, 2026 08:31AM

Jun 18, 2026 08:31AM Quoin Pharma forms Japan subsidiary to advance QRX003 commercialization

Jun 16, 2026 08:31AM

Jun 4, 2026 08:31AM

Jun 2, 2026 08:31AM

May 4, 2026 06:08AM

Apr 28, 2026 08:32AM

Mar 11, 2026 08:30AM

Jan 27, 2026 08:31AM Quoin seeks orphan drug status for QRX003 in Japan

Nov 11, 2025 08:31AM

Oct 28, 2025 08:31AM

Oct 21, 2025 08:30AM

Aug 7, 2025 09:40AM

Jul 29, 2025 08:30AM

Jun 24, 2025 08:34AM

May 22, 2025 07:31AM Quoin Pharmaceuticals Ltd (QNRX) Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study

May 14, 2025 07:30AM

Apr 30, 2025 07:31AM

Mar 25, 2025 07:31AM

Mar 4, 2025 07:30AM

Feb 27, 2025 07:31AM

Jan 23, 2025 05:30AM

Jan 14, 2025 08:34AM Quoin Pharmaceuticals (QNRX) Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Jan 6, 2025 08:33AM

Dec 20, 2024 09:20AM

Dec 18, 2024 08:18AM

Nov 5, 2024 08:02AM

Oct 22, 2024 08:01AM

Sep 9, 2024 08:33AM

Jun 12, 2024 08:14AM Quoin Pharmaceuticals (QNRX) Announces Signing of Research Agreement with University College Cork, Ireland

483,111 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All